| 000 | 01714 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250518014800.0 | ||
| 264 | 0 | _c20200702 | |
| 008 | 202007s 0 0 eng d | ||
| 022 | _a1873-460X | ||
| 024 | 7 |
_a10.1016/j.jdiacomp.2018.11.009 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHandelsman, Yehuda | |
| 245 | 0 | 0 |
_aEfficacy and safety of insulin glargine/lixisenatide (iGlarLixi) fixed-ratio combination in older adults with type 2 diabetes. _h[electronic resource] |
| 260 |
_bJournal of diabetes and its complications _c03 2019 |
||
| 300 |
_a236-242 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBlood Glucose _xanalysis |
| 650 | 0 | 4 | _aBody Weight |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aFasting |
| 650 | 0 | 4 |
_aGastrointestinal Diseases _xchemically induced |
| 650 | 0 | 4 |
_aGlycated Hemoglobin _xanalysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHypoglycemic Agents |
| 650 | 0 | 4 |
_aInsulin Glargine _xadministration & dosage |
| 650 | 0 | 4 |
_aPeptides _xadministration & dosage |
| 650 | 0 | 4 | _aPostprandial Period |
| 700 | 1 | _aChovanes, Christina | |
| 700 | 1 | _aDex, Terry | |
| 700 | 1 | _aGiorgino, Francesco | |
| 700 | 1 | _aSkolnik, Neil | |
| 700 | 1 | _aSouhami, Elisabeth | |
| 700 | 1 | _aStager, William | |
| 700 | 1 | _aNiemoeller, Elisabeth | |
| 700 | 1 | _aFrias, Juan Pablo | |
| 773 | 0 |
_tJournal of diabetes and its complications _gvol. 33 _gno. 3 _gp. 236-242 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jdiacomp.2018.11.009 _zAvailable from publisher's website |
| 999 |
_c29212031 _d29212031 |
||